95 related articles for article (PubMed ID: 10652571)
1. Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate.
Wang XM; Li J; Evers BM
Anticancer Res; 1999; 19(4B):2901-6. PubMed ID: 10652571
[TBL] [Abstract][Full Text] [Related]
2. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human gastric cancer by sodium butyrate.
Litvak DA; Hwang KO; Evers BM; Townsend CM
Anticancer Res; 2000; 20(2A):779-84. PubMed ID: 10810354
[TBL] [Abstract][Full Text] [Related]
4. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1.
Litvak DA; Evers BM; Hwang KO; Hellmich MR; Ko TC; Townsend CM
Surgery; 1998 Aug; 124(2):161-9; discussion 169-70. PubMed ID: 9706134
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-azacytidine and butyrate on differentiation and apoptosis of hepatic cancer cell lines.
Wang XM; Wang X; Li J; Evers BM
Ann Surg; 1998 Jun; 227(6):922-31. PubMed ID: 9637556
[TBL] [Abstract][Full Text] [Related]
6. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis.
Hernandez A; Thomas R; Smith F; Sandberg J; Kim S; Chung DH; Evers BM
Surgery; 2001 Aug; 130(2):265-72. PubMed ID: 11490359
[TBL] [Abstract][Full Text] [Related]
7. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
9. IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line.
Vucenik I; Tantivejkul K; Zhang ZS; Cole KE; Saied I; Shamsuddin AM
Anticancer Res; 1998; 18(6A):4083-90. PubMed ID: 9891449
[TBL] [Abstract][Full Text] [Related]
10. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP
Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652
[TBL] [Abstract][Full Text] [Related]
11. Curcumin inhibits cell cycle progression of immortalized human umbilical vein endothelial (ECV304) cells by up-regulating cyclin-dependent kinase inhibitor, p21WAF1/CIP1, p27KIP1 and p53.
Park MJ; Kim EH; Park IC; Lee HC; Woo SH; Lee JY; Hong YJ; Rhee CH; Choi SH; Shim BS; Lee SH; Hong SI
Int J Oncol; 2002 Aug; 21(2):379-83. PubMed ID: 12118335
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxycholecalciferol enhances butyrate-induced p21(Waf1/Cip1) expression.
Gaschott T; Wächtershäuser A; Steinhilber D; Stein J
Biochem Biophys Res Commun; 2001 Apr; 283(1):80-5. PubMed ID: 11322770
[TBL] [Abstract][Full Text] [Related]
13. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells.
Shieh DE; Chen YY; Yen MH; Chiang LC; Lin CC
Life Sci; 2004 Mar; 74(18):2279-90. PubMed ID: 14987952
[TBL] [Abstract][Full Text] [Related]
14. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
[TBL] [Abstract][Full Text] [Related]
16. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
18. [Effects of retinoid Ro 40-8757 on human cancer cell lines in vitro].
Lu J; Song JD
Ai Zheng; 2002 Oct; 21(10):1051-6. PubMed ID: 12508641
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
Ala-aho R; Grénman R; Seth P; Kähäri VM
Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin-dependent intercellular adhesion enhances chemoresistance.
Nakamura T; Kato Y; Fuji H; Horiuchi T; Chiba Y; Tanaka K
Int J Mol Med; 2003 Nov; 12(5):693-700. PubMed ID: 14532995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
